The gastrin releasing peptide receptor (GRPR) is a promising target for PET imaging due to its overexpression in multiple malignancies, including prostate cancer, breast cancer, gastrointestinal (GI) stromal tumors, and small-cell lung cancer [3, 4, 5, 6]. Here, GRPR is linked to prostate cancer.